An estimated 5 million people are using compounded GLP-1s in the U.S., according to a Gallup poll released in July; of the 11 ...

Claims data from Blue Cross Blue Shield of Massachusetts from 2018 through the first half of 2025 reveal that recent spending ...

The published review examines dopamine’s role in tic generation and how approved and investigational drugs may affect dopamine to reduce tics as well as synthesizes clinical trial evidence that ...

October 2, 2026“Weight dropped by 13.1% with a new injectable drug.” Seeing numbers like that might make you want to change the diabetes medication you are currently using.First, the conclusion. In a ...

New data from a phase 2b study being presented at the 2026 annual meeting of the European Association for the Study of ...

This story recreates the events of that time by having an AI read the Slack logs of Team Tamanavi. Some parts have been ...

Sept 30 (Reuters) - Patients who switched from weight-loss injections to Novo Nordisk's daily Wegovy pill continued to lose ...

Currently, no generalizable tools exist for predicting the impact of interventions on aging using gene expression changes.

Researchers published late-stage clinical trial data today for the latest obesity drug, retatrutide—expected to be the most ...

GLP-1 drugs can help with weight loss, diabetes and heart health. But do they replace statins? Know how GLP-1 medicines and statins differ and who may need both.

The FDA has warned a major compounding pharmacy that it violated federal law by making copies of blockbuster weight-loss drugs in "inordinate amounts." ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. The Trump administration's voluntary Medicaid project, BALANCE, offering lower GLP-1 prices ...